Fidelity Investments’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,424
| Closed | -$65K | – | 5466 |
|
|
2025
Q3 | $65K | Sell |
4,424
-564,581
| -99% | -$5.75M | ﹤0.01% | 3849 |
|
|
2025
Q2 | $5.59M | Sell |
569,005
-121,007
| -18% | -$1M | ﹤0.01% | 2131 |
|
|
2025
Q1 | $5.02M | Buy |
690,012
+597,845
| +649% | +$5.23M | ﹤0.01% | 2145 |
|
|
2024
Q4 | $721K | Buy |
92,167
+18,781
| +26% | +$155K | ﹤0.01% | 2783 |
|
|
2024
Q3 | $543K | Buy |
73,386
+70,129
| +2,153% | +$590K | ﹤0.01% | 2817 |
|
|
2024
Q2 | $26.1K | Sell |
3,257
-163
| -5% | -$1.46K | ﹤0.01% | 3949 |
|
|
2024
Q1 | $39.8K | Buy |
3,420
+43
| +1% | +$476 | ﹤0.01% | 3692 |
|
|
2023
Q4 | $37.7K | Buy |
3,377
+2,617
| +344% | +$24.1K | ﹤0.01% | 3646 |
|
|
2023
Q3 | $11.7K | Sell |
760
-1,357
| -64% | -$22.8K | ﹤0.01% | 4046 |
|
|
2023
Q2 | $40.1K | Buy |
2,117
+97
| +5% | +$1.7K | ﹤0.01% | 3543 |
|
|
2023
Q1 | $30.8K | Sell |
2,020
-59
| -3% | -$769 | ﹤0.01% | 3651 |
|
|
2022
Q4 | $26.5K | Hold |
2,079
| – | – | ﹤0.01% | 3671 |
|
|
2022
Q3 | $12K | Hold |
2,079
| – | – | ﹤0.01% | 4014 |
|
|
2022
Q2 | $7K | Sell |
2,079
-710,131
| -100% | -$2.14M | ﹤0.01% | 4213 |
|
|
2022
Q1 | $2.68M | Buy |
712,210
+74,684
| +12% | +$481K | ﹤0.01% | 2527 |
|
|
2021
Q4 | $8.33M | Sell |
637,526
-13,674
| -2% | -$216K | ﹤0.01% | 2189 |
|
|
2021
Q3 | $12.8M | Sell |
651,200
-18,670
| -3% | -$341K | ﹤0.01% | 2024 |
|
|
2021
Q2 | $12.5M | Buy |
669,870
+236,830
| +55% | +$5.29M | ﹤0.01% | 2019 |
|
|
2021
Q1 | $10.3M | Sell |
433,040
-20,700
| -5% | -$478K | ﹤0.01% | 2028 |
|
|
2020
Q4 | $11.1M | Buy |
453,740
+434,540
| +2,263% | +$11.1M | ﹤0.01% | 1936 |
|
|
2020
Q3 | $493K | Buy |
+19,200
| New | +$609K | ﹤0.01% | 2535 |
|
Other funds holding ETNB
Fidelity Investments's ETNB Position: Q4 2025 in Review
Fidelity Investments sold out of 89bio (ETNB) in Q4 2025, closing a stake of 4,424 shares — an estimated $65K sold.
Fidelity Investments first reported a position in ETNB in Q3 2020 and held it in 21 quarters. The position peaked at $12.8M in Q3 2021. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Fidelity Investments reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Fidelity Investments sold 4,424 89bio shares in Q4 2025, an estimated $65K.
- Fidelity Investments first reported a position in 89bio in Q3 2020 and held it in 21 quarters.
- Fidelity Investments's 89bio position peaked at $12.8M in Q3 2021.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.